A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia

British Journal of Haematology

Volumn 93, Issue 3, 1996, Pages 637-646

  Ringden O ^a   Labopin, M ^b   Tura, S ^c   Arcese, W ^d   Iriondo, A ^e   Zittoun, R ^f   Sierra, J ^g   Gorin, N C ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b HÔPITAL SAINT ANTOINE   (France)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e Hospital National   (Spain)

^f HÔTEL DIEU   (France)

^g HOSPITAL CLÍNIC   (Spain)

Author keywords

Acute leukaemia; Bone marrow transplantation; Busulphan; Cyclophosphamide; Total body irradiation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; WHOLE BODY RADIATION;

EID: 0029892605     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1681.x     Document Type: Article

References (17)

1. Blaise, D., Maraninchi, D., Archimbaud, E., Reiffers, J., Devergie, A., Jouet, J.P., Milpied, N., Attal, M., Michallet, M., Ifrah, N., Kuentz, M., Dauriac, C., Bordigoni, P., Gratecos, N., Fuilhot, F., Guyotat, D., Gouvernet, J. & Gluckman, E. (1992) Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen. A report from the Groupe d'Études de la Greffe de Moelle Osseuse. Blood, 79, 2578-2582.
2. Clift, R.A., Buckner, C.D., Thomas, E.D., Bensinger, W.I., Bowden, R., Bryant, E., Deeg, H.J., Doney, K.C., Fisher, L.D., Hansen, J.A., Martin, P., McDonald, G.B., Sanders, J.E., Schoch, G., Singer, J., Storb, R., Sullivan, K.M., Witherspoon, R.P. & Appelbaum, F.R. (1994) Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood, 84, 2036-2043.
3. Copelan, E.A., Biggs, J.C., Thompson, J.M., Crilley, P., Szer, J., Klein, J.P., Kapoor, N., Avalos, B.R., Cunningham, I., Atkinson, K., Downs, K., Harmon, G.S., Daly, M.B., Brodsky, L. Bulova, S.I. & Tutscha, P.J. (1991) Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood, 73, 838-843.
4. Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Statistical Society B., 34, 187-220.
5. Deeg, H.J., Flournoy, N., Sullivan, K.M., Sheehan, K., Buckner, C.D., Sanders, J.E., Storb, R., Witherspoon, R.P. & Thomas, E.D. (1984) Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. International Journal of Radiation Oncology and Biological Physics, 10, 957-964.
6. Dusenbery, K.E., Daniels, K.A., McClure, J.S., McGlave, P.B., Ramsay, N.K., Blazar, B.R., Neglia, J.P., Kersey, J.H. & Woods, W.G. (1995) Randomized comparison of cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukaemia. International Journal of Radiation Oncology and Biological Physics, 31, 119-128.
7. Frassoni, F., Labopin, M., Gluckman, E., Prentice, G.P., Vernant, J.P., Zwaan, F., Granenon, A., Gahrton, G., DeWitte, T., Gratwohl, A., Reiffers, J. & Gorin, N.C. (1996) Results of allogeneic bone marrow transplantation for acute leukaemia have improved over time in Europe. Bone Marrow Transplantation, 17, 13-18.
8. Gorin, N.C., Labopin, M., Meloni, G., Korbling, M., Carella, A., Herve, P., Burnett, A., Rizzoli, V., Alessandrino, E.P., Björkstrand, B., Ferrant, A., Lowenberg, B., Coser, P., Simonsson, B., Helbig, W., Brunet-Mauri, S., Verdonck, L.F., Iriondo, A., Polli, E., Colombat, P., Franklin, I.M., Souillet, G. & Willemze, R. (1991) Autologous bone marrow transplantation for acute myeloblastic leukaemia in Europe: further evidence of the role of marrow purging by mafosfamide. Leukaemia, 5, 896-904.
9. Kaplan, E.I. & Meier, P. (1958) Non-parametric estimation for incomplete observations. Journal of the American Statistical Association, 53, 457-481.
10. Ringdén, O., Ruutu, T., Remberger, M., Nikoskelainen, J., Volin, L., Vindeløv, L., Parkkali, T., Lenhoff, S., Sallerfors, B., Ljungman, P., Mellander, L. & Jacobsen, N., for the Nordic Bone Marrow Transplantation Group (1994) A randomized trial comparing busulphan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood, 83, 2723-2730.
11. Sanders, J.E., and the Seattle Marrow Transplant Team (1991) The impact of marrow transplant preparative regimens on subsequent growth and development. Seminars in Hematology, 28, 244-249.
12. Santos, G.W., Tutschka, P.J., Brookmeyer, R., Saral, R., Beschorner, W.E., Bias, W.B., Braine, H., Burns, W.H., Elfenbein, G.J., Kaizer, H., Mellits, D., Sensenbrenner, L.L., Stuart, R.K. & Yeager, A.M. (1983) Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. New England Journal of Medicine, 309, 1347-1353.
13. Tutschka, P.J., Copelan, E.A. & Klein, J.P. (1987) Bone marrow transplantation following a new busulfan and cyclophosphamide regimen. Blood, 70, 1382-1388.
14. Weiden, P.L., Flournoy, N., Thomas, E.D., Prentice, R., Fefer, A., Buckner, C.D. & Storb, R. (1979) Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. New England Journal of Medicine, 300, 1068-1073.
15. Weiner, R.S., Bortin, M.M., Gale, R.P., Gluckman, E., Kay, H.E., Kolb, H.J., Hartz, A.J. & Rimm, A.A. (1986) Interstitial pneumonitis after bone marrow transplantation: assessment of risk factors. Annals of Internal Medicine, 104, 168-175.
16. Wingard, J.R., Plotnich, L.P., Freemer, C.S., Zahurak, M., Piantadosi, S., Miller, D.F., Vriesendorp, H.M., Yeager, A.M. & Santos, G.W. (1992) Growth in children after bone marrow transplantation: busulphan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood, 79, 1068-1073.
17. Witherspoon, R.P., Fischer, L.D., Schoch, G., Martin, P., Sullivan, K.M., Sanders, J., Deeg, H.J., Doney, K., Thomas, X.D., Storb, R. & Thomas, E.D. (1989) Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. New England Journal of Medicine, 321, 784-789.